Pyridine

Pyridine

SCHEMBL6603891

NC(=O)c1ncc[nH]1.c1ccncc1.c1ccncc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 1/20 0.42
TYRO3 Q06418 1/20 0.42
DYRK1B Q9Y463 1/20 0.42
KMT2A Q03164 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
SARM1 Q6SZW1 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
SIRT6 Q8N6T7 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
SIRT3 Q9NTG7 1/20 0.36
SIRT5 Q9NXA8 1/20 0.36
SIRT4 Q9Y6E7 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CCNC P24863 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL9978894 1.00 CSNK1A1 (0.42) CSNK1A1TYRO3DYRK1BKMT2ANPC1
Piperazine SCHEMBL28251008 0.93 CSNK1A1 (0.39) CSNK1A1TYRO3DYRK1BKMT2ANPC1
SCHEMBL34651 0.88
Hydrochloric Acid SCHEMBL4023730 0.86 NPC1 (0.47) CSNK1A1TYRO3DYRK1BKMT2ANPC1
SCHEMBL9786602 0.86
Hydrochloric Acid SCHEMBL4244388 0.86
Pyridine SCHEMBL6603492 0.85 KMT2A (0.45) CSNK1A1TYRO3DYRK1BKMT2ANPC1
Biphenyl SCHEMBL27718930 0.84 CSNK1A1 (0.49) CSNK1A1TYRO3DYRK1BKMT2ANPC1
Pyrrole SCHEMBL1577642 0.83 CSNK1A1 (0.44) CSNK1A1TYRO3DYRK1BKMT2ANPC1
SCHEMBL25335480 0.81 CSNK1A1 (0.42) CSNK1A1TYRO3DYRK1BKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1023291-B1 DIPYRIDOIMIDAZOLDERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS ORTHO MCNEIL PHARM INC (US) 2004-05-26 EP disclosed
EP-1023291-A1 DIPYRIDOIMIDAZOLDERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS Ortho-McNeil Pharmaceutical, Inc. (US) 2000-08-02 EP disclosed
US-5968946-A FUSED PYRROLO-IMIDAZOPYRIDINE DERIVATIVES ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-10-19 US disclosed
WO-1999040092-A1 OXO-DIPYRIDOIMIDAZOLE-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1999-08-12 WO disclosed
WO-1999018105-A1 DIPYRIDOIMIDAZOLDERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-04-15 WO disclosed